Dennis M. Lanfear, President and CEO at Coherus BioSciences, Inc. (CHRS), sold 8,070 shares at $31.75 ($256K) on 2016-09-20, disclosed to the SEC on 2016-09-22.
Open-market sale of $256k CHRS by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.75 | 4,010 | $127K | 49.7% |
| 2 | $31.75 | 4,010 | $127K | 49.7% |
| 3 | $31.75 | 50 | $2K | 0.6% |
| Total | $31.75 avg | 8,070 | $256K | 100% |
| Filing → |
| CHRS | SELL | 2019-11-25 | $464K | — | Filing → |
| CHRS | SELL | 2019-11-22 | $14.8M | — | Filing → |
| CHRS | SELL | 2019-05-31 | $1.3M | — | Filing → |